GVHD
Clinical trials for GVHD explained in plain language.
Never miss a new study
Get alerted when new GVHD trials appear
Sign up with your email to follow new studies for GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood cancer drug repurposed to prevent transplant complication
Disease control TerminatedThis study looked at whether telmisartan, a blood pressure medicine, could prevent acute graft-versus-host disease (GVHD) in people receiving a stem cell transplant for blood cancers. About 32 participants were enrolled, but the trial was stopped early. The main goal was to see h…
Matched conditions: GVHD
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
Experimental drug aims to tame Life-Threatening transplant complication
Disease control TerminatedThis study tested a drug called apraglutide in people who developed severe gut graft-versus-host disease (GVHD) after a stem cell transplant and did not respond to steroids. The goal was to see if the drug is safe and can help control the disease. The trial was stopped early and …
Matched conditions: GVHD
Phase: PHASE2 • Sponsor: VectivBio AG • Aim: Disease control
Last updated May 20, 2026 11:54 UTC